Pangaea Data is headquartered in London with offices in San Francisco and Hong Kong. Pangaea provides an AI driven software product, which has proven to find 50% more suitable patients including those who are undiagnosed and to automatically generate clinical narratives for regulatory reports thereby saving 80 - 90% in time. This is achieved through Pangaea's novel unsupervised Natural Language Processing (NLP) and first of its kind Natural Language Generation (NLG) methods which respectively extract and summarize intelligence from textual and multi-modal health data at scale and in a federated privacy preserving manner. Pangaea's product has demonstrated 85 - 90% accuracy through high impact peer reviewed publications, which is transformatively higher than generic language models like GPT-3, supervised NLP, and relational extraction approaches.
Pangaea's product has successfully scaled in the pharmaceutical and healthcare industry and has been presented by leading clinicians and scientists at global conferences. The founders at Pangaea have secured more than £130 million in research funding through their work. All customer success stories and peer reviewed publications including comparisons to alternative approaches with evidence of efficacy through a combination of context, reinforcement learning, and 'human experts (clinicians) in the loop' are available freely through Pangaea's website.